NCT06108219 Phase 2 Completed
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) Corcept Therapeutics
Primary completion 2026-02-13 ACTUAL
Enrollment 175 ACTUAL
Source updated 2026-09-28 Values from available record
Version history
What changed Last 12 months Pro unlocks the full available history and CSV export.
Explore Pro 2026-09-28 Completion Type Recorded edit
− Previous value ESTIMATED
Registry posting date ·
View source 2026-09-28 Primary Completion Recorded edit
+ Updated value 2026-02-13
Registry posting date ·
View source 2026-09-28 Status Recorded edit
− Previous value ACTIVE_NOT_RECRUITING
Registry posting date ·
View source 2025-09-30 Enrollment Type Recorded edit
− Previous value ESTIMATED
Registry posting date ·
View source 2025-09-30 Enrollment Recorded edit
− Previous value count: 195; type: ESTIMATED
+ Updated value count: 175; type: ACTUAL
Registry posting date ·
View source 2025-09-30 Primary Completion Recorded edit
Registry posting date ·
View source Coverage is a sample, not a complete track record. Selected historical fields and versions may omit edits; endpoint text may be truncated. Read our methodology